In this double-blind study with a placebo control, the effectiveness of resveratrol as a supplementary treatment for clinical indicators (PD, CAL, PI, and BI) and salivary inflammatory indicators (IL-8 and IL-1β) was investigated in chronic periodontitis patients without any systemic disease. Here, CXCL8 is linked to chronic periodontitis.